Clinical Trials

Search for actively enrolling clinical trials

AEWS1221, Randomized Phase 3 Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479, NSC# 750008, IND# 120449) to Multiagent Chemotherapy for Patients with Newly Diagnosed Metastatic Ewing Sarcoma

Study ID: STU 122014-025

Summary

See protocol/CiRB application

Participant Eligibility

See protocol

Cancer Related
Healthy Volunteers
No
UT Southwestern Principal Investigator
Patrick J Leavey

Contact:

AMANDA RICHARDS

AMANDA.RICHARDS@childrens.com

Linked In Email
scroll to top